-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Seres Therapeutics, Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from 2013 to 2023.
- Seres Therapeutics, Inc. Depreciation, Depletion and Amortization for the quarter ending September 30, 2024 was $1.4M, a 16.6% decline year-over-year.
- Seres Therapeutics, Inc. Depreciation, Depletion and Amortization for the twelve months ending September 30, 2024 was $6.02M, a 3.58% decline year-over-year.
- Seres Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2023 was $6.24M, a 5.82% decline from 2022.
- Seres Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2022 was $6.63M, a 11.5% increase from 2021.
- Seres Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2021 was $5.95M, a 9.59% decline from 2020.
Depreciation, Depletion and Amortization, Trailing 12 Months (USD)
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Growth (%)